Most children infected with COVID-19 will not require care in a hospital and can be safely managed in the community.
The team responsible for the care of a child with COVID-19 will vary according to local resourcing, geographic location and service models. The team should be multidisciplinary and include clinicians with paediatric expertise.
This advice is adapted from the Sydney Children’s Hospitals Network guidance; and this guideline was developed in consultation with the network. It outlines guidance to assist health staff to:
This is relevant to babies and children up to 16 years of age, or when they transition to adult services.
This guide aligns with
Caring for adults with COVID-19
in the community.
It should be read in conjunction with local health district COVID-19 management guidelines, as well as the following state and national resources addressing clinical care of people with COVID-19, virtual care and infection control:
Use of this guideline and other policy documents will be underpinned by local factors. These include location and demographics; as well as service factors, such as leadership, governance, resources and policies/procedures.
Expert advice was sought in the development of this guideline from clinicians across the state, the Sydney Children's Hospitals Network Virtual Care team, the Agency for Clinical Innovation (ACI) Virtual Care team and the ACI COVID-19 Critical Intelligence Unit.
COVID-19 is a notifiable disease and positive cases are notified to the local public health unit (PHU) based on the person's usual place of residence.
PHUs are responsible for arranging ongoing clinical and welfare support. This may be provided by the local health district (LHD) service, such as a COVID-19 team, a community team, virtual care service or Hospital in the Home (HITH). These services will:
LHDs must develop appropriate local referral pathways into their community, virtual care or HITH team for COVID positive patients. These teams should include clinicians with capabilities in the care of children.
Common symptoms of COVID-19 in children include rhinorrhea, sore throat, fever, cough and gastrointestinal symptoms. These features are usually mild.
Features of concern are breathlessness/difficulty breathing, syncope/dizziness, chest pain, severe headache, decreased level of consciousness, significant vomiting and diarrhoea and poor fluid intake or output. Children with these features require prompt clinical review.
Children more likely to require care in hospital or develop more severe disease include those who are immunocompromised; have pre-existing medical conditions; are severely obese or pregnant.
Adolescents and babies under three months of age (corrected for prematurity) are at a relatively higher risk.
Safe care of children in the community depends on the health and wellbeing of parents/carers.
Due to the contagious nature of this illness, household contacts are likely to also develop COVID-19. The health risks of parents/carers with COVID-19, especially if unvaccinated, should be identified - refer to
Caring for adults in the community with COVID-19.
Plans should be made for continuing care of the children if the parent/carer becomes unwell or requires hospitalisation.
Other high-risk factors include:
The stresses of quarantine add to the challenges for these households.
Support may include a social work response, Department of Community and Justice, Police welfare checks, mental health services and the families' general practitioner.
Paediatric inflammatory multisystem syndrome temporarily associated with SARS Co-V (PIMS-TS) has been associated with COVID-19 infection in children.1 It is also known as multisystem inflammatory syndrome in children (MIS-C).
This is a rare condition affecting approximately 1/1,000 children after COVID-19 infection, including asymptomatic or mild infection.
It presents two to six weeks after infection of COVID-19. The child may return a negative polymerase chain reaction (PCR) test at that time.
Clinical features include fever, rash, gastrointestinal symptoms and shock.
Families should be advised to look out for these features and seek prompt medical care if any of these occur.
Parents/carers must be provided with resources to enable safe care in the community. This can include information about the relevant health service; devices and data to enable virtual care or telehealth (if needed); monitoring equipment; and telephone numbers for the local telehealth service and 000 for ambulance.
Pulse oximeters may be used for intermittent or 'spot' measurement for scheduled health reviews. It requires several minutes to obtain a reliable reading and can be difficult in children under 12 years of age. Appropriate oximeters and probes should be used in younger children if oximetry is performed.
The decision to de-isolate children and families is led by the LHD public health unit. Criteria for de-isolation can be found at Communicable Diseases Network Australia (CDNA) - Coronavirus Disease
CDNANational guidelines for public health units.
Formal arrangements for transfer of clinical care back to the GP should be made by the COVID-19 medical team. A formal transfer of care should be given to the GP, including a written summary of the person's episode of care and follow-up advice.
It is a requirement that all clinical activity, including telehealth consultations, is documented in the person's health record.
Patient care is tailored to individual risk. During the initial phone call, follow the flow chart using the patient's information. Once the level of risk is determined, see associated box for care package.
Note: days are calculated based on the days that symptoms commenced (day 0). If the patient is asymptomatic, count from positive swab day (day 0).
Deterioration may be detected by the patient, parent carers or clinicians.
Virtual Care Community of Practice working group
Dr Nigel Lyons, Deputy Secretary, Health System Strategy and Planning, NSW Ministry of Health.
Clinicians delivering virtual and clinical care to people with COVID-19 in the community, including: